home / lobbying / lobbying_activities

lobbying_activities: 2341448

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id filing_uuid filing_type registrant_name registrant_id client_name filing_year filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
2341448 bed7753e-3296-4e8d-b9f1-1cbc4bc6ab82 Q3 JAMES EDWARDS 401027897 CONSERVATIVES FOR PROPERTY RIGHTS 2019 third_quarter CPT S. 2082/H.R. 3666 (STRONGER Patents Act) Trade-related intellectual property policy/practices/encroachment by foreign countries/companies against U.S. competitiveness interests - China, Committee on Foreign Investment in the United States review of Chinese acquisitions and joint ventures, United States-Mexico-Canada Agreement IP chapter, International Trade Commission exclusion of U.S. patent-infringing imports, ITC baseband chip set patent infringement remedy Piracy of online and streaming copyrighted content Compulsory licensing - S. 377/H.R. 1046 (Medicare Negotiation and Competitive Licensing Act), S. 102/H.R. 465 (Prescription Drug Price Relief Act), S. 977 (Transparent Drug Pricing Act) NIST Return on Investment Initiative for Unleashing American Innovation S. 344/H.R. 990 (Hatch-Waxman Integrity Act) FTC/patent licensing as exclusive property right Bayh-Dole Act/technology transfer Procedural and evidentiary standards used at Patent Trial and Appeal Board PTO patentable subject matter eligibility guidance Section 101 patentable subject matter reform Injunctive relief from willful infringement DOJ-DOC withdrawal of 2013 Policy Statement on Remedies for Standards-Essential Patents Subject to Voluntary F/RAND Commitments S. 1273/H.R. 2426 (Copyright Alternative in Small-Claims Enforcement (CASE) Act) S. 1416/H.R.3991 (Affordable Prescriptions for Patients Act) Obviousness/No Combination Drug Patents Act Patent licensing/standards-essential patents Army, Dept of (Corps of Engineers),Centers For Medicare and Medicaid Services (CMS),Environmental Protection Agency (EPA),Executive Office of the President (EOP),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Patent & Trademark Office (PTO),SENATE,U.S. Trade Representative (USTR)     0 0 2019-10-14T14:24:10.167000-04:00
Powered by Datasette · Queries took 12.643ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API